Underinsurance among children in the United States

Michael D Kogan1, Paul W Newacheck, Stephen J Blumberg

  • 1Maternal and Child Health Bureau, Health Resources and Services Administration, Department of Health and Human Services, Rockville, MD 20857, USA. mkogan@hrsa.gov

Insights

Millions of children are underinsured, meaning their health insurance doesn't adequately cover needs. This underinsurance impacts healthcare access and quality for many children.

Area of Science:

  • Pediatric Health Services Research
  • Health Insurance Policy
  • Healthcare Access and Quality

Background:

  • Policy discussions on children's health insurance have primarily focused on coverage expansion.
  • There has been limited attention to whether existing insurance adequately meets children's healthcare needs.

Purpose of the Study:

  • To estimate the prevalence of underinsurance among U.S. children.
  • To examine the association between insurance status (including underinsurance) and healthcare access and quality indicators.

Main Methods:

  • Utilized data from the 2007 National Survey of Children's Health (n=91,642).
  • Classified children based on insurance continuity and adequacy (coverage of services, providers, and costs).
  • Assessed associations with delayed/forgone care, specialist access, preventive care, developmental screening, and medical home criteria.

Main Results:

  • In 2007, 14.1 million children with continuous insurance were underinsured (22.7%).
  • Underinsured children were more likely to experience problems with healthcare access and quality compared to adequately insured children.
  • Older, Hispanic, less healthy children, and those with special healthcare needs were more likely to be underinsured.

Conclusions:

  • The number of underinsured children surpassed those uninsured for part of the year.
  • Healthcare access and quality remain suboptimal for uninsured and underinsured children.
  • Findings highlight the critical issue of underinsurance in pediatric health policy.
Abstract

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
Introduction To Health Care Delivery System01:18

Introduction To Health Care Delivery System

The healthcare system is constantly changing and complex. Various services are available from different healthcare providers, but gaining access to these services has become challenging for people with limited healthcare insurance. Uninsured people present a challenge to healthcare because they frequently postpone or forego treatment.
The Institute of Medicine (IOM) advocates for a patient-centered, effective, safe, timely, equitable, and effective healthcare system. The National Priorities...